Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes

Infection and Immunity

Volumn 67, Issue 12, 1999, Pages 6526-6532

  Lehmann, A K ^a   Gorringe, A R ^b   Reddin, K M ^b   West, K ^b   Smith, I ^a   Halstensen, A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; OPSONIN; TRANSFERRIN;

ADOLESCENT; ADULT; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; MALE; MENINGOCOCCOSIS; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IRON-BINDING PROTEINS; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; OPSONIN PROTEINS; PHAGOCYTOSIS; RESPIRATORY BURST; TRANSFERRIN-BINDING PROTEINS;

EID: 0032723012     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aase, A., and T. E. Michaelsen. 1994. Opsonophagocytosis activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Scand. J. Immunol. 39:581-587.
2. Ala'Aldeen, D. A. A., P. Stevenson, E. Griffiths, A. Gorringe, L. I. Irons, A. Robinson, S. Hyde, and S. P. Borriello. 1994. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect. Immun. 62:2984-2990.
3. Ala'Aldeen, D. A. A., and E. Griffiths. 1995. Vaccines against meningococcal diseases, p. 1-39. In D. A. A. Ala'Aldeen and C. E. Hormaeche (ed.), Molecular and clinical aspects of bacterial vaccine development. John Wiley & Sons Ltd., Chichester, England.
4. Ala'Aldeen, D. A. A., and S. P. Borriello. 1996. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Vaccine 14:49-53.
5. Bjune, G., E. A. Høiby, J. K. Grønnesby, Ø. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A.-K. Lindbak, H. Nøkleby, E. Rosenqvist, L. K. Solberg, O. Closs, J. Eng, L. O. Frøholm, A. Lystad, L. S. Bakketeig, and B. Hareide. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
6. Boulton, I. C., A. R. Gorringe, N. Allison, A. Robinson, B. Gorinsky, C. L. Joannou, and R. W. Evans. 1998. Transferrin binding protein B isolated from Neisseria meningitidis discriminates between apo and diferrin human transferrin. Biochem. J. 334:269-273.
7. Bredius, R. G. M., B. H. F. Derkx, A. P. Fijen, T. P. M. de Wit, M. de Haas, R. S. Weening, J. G. J. van de Winkel, and T. A. Out. 1994. Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal shock in children. J. Infect. Dis. 170:848-853.
8. Burton, D. R., L. Gregory, and R. Jefferis. 1986. Aspects of the molecular structure of IgG subclasses. Monogr. Allergy 50:510-516.
9. Cornelissen, C. N., M. Kelley, M. M. Hobbs, J. E. Anderson, J. G. Cannon, M. S. Cohen, and P. F. Sparling. 1998. The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol. Microbiol. 27:611-616.
10. Danve, B., L. Lissolo, M. Mignon, P. Dumas, S. Colombani, A. B. Schryvers, and M.-J. Quentin-Millet. 1993. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine 11:1214-1220.
11. Danve, B., L. Lissolo, F. Guinet, E. Boutry, D. Speck, M. Cadoz, W. Nassif, and M. J. Quentin-Millet. 1998. Safety and immunogenicity of a Neisseria meningitidis groupB transferrin binding protein vaccine in adults, p. 53. In X. Nassif, M.-J. Quentin-Millet, and M.-K. Taha (ed.), Abstracts of the Eleventh International Pathogenic Neisseria Conference, 1 to 6 November 1998, Nice, France. Editions E.D.K., Paris, France.
12. Ferreiros, C. M., L. Ferron, and M. T. Criado. 1994. In vivo human immune response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis. FEMS Immun. Med. Microbiol. 8:63-68.
13. Figueroa, J. E., and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359-395.
14. Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjune, L. O. Frøholm, A. K. Lindbak, B. Møgster, E. Namork, U. Rye, G. Stabbetorp, R. Winsnes, B. Aase, and O. Closs. 1991. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14:67-80.
15. Gorringe, A. R., R. Borrow, A. J. Fox, and A. Robinson. 1995. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine 13:1207-1212.
16. Gray-Owen, S. D., and A. B. Shryvers. 1996. Bacterial transferrin and lactoferrin receptors. Trends Microbiol. 4:185-191.
17. Griffiths, E., G. Sierra, and J. Holst. 1994. Quality control of the Cuban and Norwegian serogroup B vaccines used in the Iceland study, p. 437-438. In J. S. Evans, S. E. Jost, M. C. J. Maiden, and I. M. Feavers (ed.), Neisseria 94. Proceedings of the Ninth International Pathogenic Neisseria Conference, Winchester, United Kingdom.
18. Guttormsen, H.-K., R. Bjerknes, A. Næss, V. Lehmann, A. Halstensen, S. Sørnes, and C. O. Solberg. 1992. Cross-reacting serum opsorins in patients with meningococcal disease. Infect. Immun. 60:2777-2783.
19. Halstensen, A., H. Sjursen, S. E. Vollset, L. O. Frøholm, A. Næss, R. Matre, and C. O. Solberg. 1989. Serum opsonins to serogroup B meningococci in meningococcal disease. Scand. J. Infect. Dis. 21:267-276.
20. Johnson, A, S., A. R. Gorringe, A. J. Fox, R. Borrow, and A. Robinson. 1997. Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis. FEMS Immunol. Med. Microbiol. 19:159-167.
21. Lehmann, A. K., A. Halstensen, J. Holst, and C.-F. Bassøe. 1997. Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis. J. Immunol. Methods 200:55-68.
22. Lehmann, A. K., A. Halstensen, and C.-F. Bassøe. 1998. Flowcytometric quantitation of human opsonophagocytosis and oxidative burst responses to meningococcal antigens. Cytometry 33:406-413.
23. Lehmann, A. K., A. Halstensen, I. S. Aaberge, J. Holst, T. E. Michaelsen, S. Sørnes, L. M. Wetzler, and H.-K. Guttormsen. 1999. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect. Immun. 67:2552-2560.
24. Lissolo, L., G. Maitre-Wilmotte, P. Dumas, M. Mignon, B. Danve, and M.-J. Quentin-Millet. 1995. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect. Immun. 63:884-890.
25. Pintor, M., L. Ferron, J. A. Gomez, N. B. L. Powell, D. A. A. Ala'Aldeen, S. P. Borriello, M. T. Criado, and C. M. Ferreiros. 1996. Blocking of iron uptake from transferrin binding proteins in Neisseria meningitidis. Microb. Pathog. 20:127-139.
26. Raff, H. V., D. Devereux, W. Shuford, D. Abbot-Brown, and G. Maloney. 1988. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections. J. Infect. Dis. 157:118-126.
27. Rokbi, B., V. Mazarin, G. Maitre-Wilmotte, and M.-J. Quentin-Millet. 1993. Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol. Lett. 110:51-58.
28. Ross, S. C., P. J. Rosenthal, H. M. Berberich, and P. Densen. 1987. Killing of Neisseria meningilidis by human neutrophils: implications for normal and complement-deficient individuals. J. Infect. Dis. 155:1266-1275.
29. Rothe, G., A. Oser, and G. Valet. 1988. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil activity in neutrophil granulocytes. Naturwissenschaften 75:354-355.
30. Schlesinger, M., R. Greenberg, J. Levy, H. Kaythy, and R. Levy. 1994. Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J. Infect. Dis. 170:449-453.
31. Van de Winkel, J. G. J., and P. J. A. Capel. 1993. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 14:215-221.